Name: FibroBiologics, Inc. (FBLG) Financial Statements
Creator: FinSpry

FibroBiologics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

FibroBiologics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	4.50	2.37	1.15	0.52	0.67
Selling, General & Administrative	9.23	6.52	3.32	1.06	0.50
Operating Expenses	13.74	8.89	4.47	1.58	1.17
Operating Income	-13.74	-8.89	-4.47	-1.58	-1.17
Other Income/Expense
Interest Income	0.25	0.00	0.00	0.00	0.00
Interest Expense	0.02	0.15	0.65	0.00	0.00
Other Income/Expense	2.58	-7.45	0.00	0.00	0.00
Income
Income Before Tax	-11.16	-16.49	-5.12	-1.58	-1.17
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-11.16	-16.49	-5.12	-1.58	-1.17
Net Income - Continuous Operations	-11.16	-16.49	-5.12	-1.58	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-10.57	-15.90	-4.37	-1.58	0.00
EBIT	-11.14	-16.34	-4.47	-1.58	-1.17
Depreciation & Amortization	0.57	0.44	0.09	0.00	0.00
Earnings Per Share
Basic EPS	-	-1.00	-	-	-
Diluted EPS	-	-1.00	-	-	-
Basic Shares Outstanding	32.88	32.49	32.48	32.48	8.75
Diluted Shares Outstanding	32.88	32.49	32.48	32.48	8.75